Rankings
▼
Calendar
ANIK Q4 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
Q4 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$40M
+10.6% YoY
Gross Profit
$24M
60.9% margin
Operating Income
-$7M
-16.8% margin
Net Income
-$5M
-12.4% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
-1.6%
Cash Flow
Operating Cash Flow
$481,000
Free Cash Flow
-$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$349M
Total Liabilities
$64M
Stockholders' Equity
$286M
Cash & Equivalents
$86M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$40M
$36M
+10.6%
Gross Profit
$24M
$18M
+33.1%
Operating Income
-$7M
-$9M
+26.9%
Net Income
-$5M
-$6M
+15.3%
Revenue Segments
OA Pain Management
$24M
60%
Joint Preservation and Restoration
$14M
36%
Non-Orthopedic
$2M
4%
Geographic Segments
UNITED STATES
$32M
87%
Europe
$5M
13%
← FY 2022
All Quarters
Q1 2023 →